Whereas Xu et al determined prostein expression in a collection of PCa tissues and normal prostate samples, we expanded this study by using matched pairs of tumourous and nontumourous prostate tissue for the mRNA quantification. The gene discussed is SLC45A3; the disease is posterior cortical atrophy.